WASHINGTON, D.C.-Instead of going back to academia, former FDA Commissioner and Medicare Administrator Mark McClellan, MD, is setting up his own shop to tackle health reform and drug safety more actively. Dr. McClellan will head the Engelberg Center for Health Care Reform at the Brookings Institution, starting with $20 million in funding from Alfred Engelberg and Leonard Schaeffer.
WASHINGTON, D.C.-Instead of going back to academia, former FDA Commissioner and Medicare Administrator Mark McClellan, MD, is setting up his own shop to tackle health reform and drug safety more actively. Dr. McClellan will head the Engelberg Center for Health Care Reform at the Brookings Institution, starting with $20 million in funding from Alfred Engelberg and Leonard Schaeffer.
One initial project is to help revise Medicare payments to physicians and other providers, which have been the subject of heated debate for several years. Dr. McClellan will work closely with Dartmouth Atlas Project researchers in modeling new approaches for updating provider payments.
As the former administrator of the Centers for Medicare and Medicaid Services (CMS), Dr. McClellan also is weighing in on the debate over renewing the State Children's Health Insurance Plan (SCHIP) this year, as well as broader health reform proposals that are surfacing as part of the 2008 presidential campaign.
Extending the Capabilities of the EHR Through Automation
August 2nd 2023Welcome back to another episode of "Tuning In to the C-Suite," where Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of chatting with Cindy Gaines, chief clinical transformation officer at Lumeon.
Listen